Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 78, Issue 1, 1998, Pages 79-81

  Imai, Atsushi ^a   Horibe, Shinji ^a   Takagi, Atsushi ^a   Takagi, Hiroshi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometriosis; Menses; Tumor marker

Indexed keywords

BUSERELIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; DIAGNOSTIC ERROR; DISEASE MARKER; ENDOMETRIOSIS; FEMALE; HUMAN; LABORATORY TEST; MENSTRUAL CYCLE; MENSTRUATION DISORDER; PRIORITY JOURNAL;

EID: 0031965546     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00003-7     Document Type: Article

References (8)

1. Niloff J.M., Knapp R.C., Schaetzl E., Reynolds C., Bast R.C. CA125 serum levels in obstetric and gynecologic patients. Obstet Gynecol. 64:1984;703-707.
2. Canny P.A., Wilkinson P.M., James R.D., Moore M. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125. Br J Cancer. 52:1985;131-133.
3. Negishi Y., Iwabuchi H., Sakunaga H., Sakamoto M., Okabe K., Sato H., Asano G. Serum and tissue measurement of CA72-4 in ovarian cancer patients. Gynecol Oncol. 48:1993;148-154.
4. Kan Y.Y., Yeh S.H., Ng H.T., Lou C.M. Effect of menstruation on serum CA125 levels. Asia-Oceania J Obstet Gynecol. 18:1992;339-343.
5. Lehtovirta P., Apter D., Stenman U.H. Serum CA125 levels during menstrual cycle. Br J Obstet Gynecol. 97:1990;930-933.
6. Pittaway D.E., Fayez J.A. Serum CA125 antigen levels increase during menses. Am J Obstet Gynecol. 156:1987;75-76.
7. Masahashi T., Matsuzawa K., Ohsawa M., Narita O., Asai T., Ishihara M. Serum CA125 levels in patients with endometrisosis: changes in CA125 levels during menstruation. Obstet Gynecol. 72:1988;328-331.
8. Tamakoshi K., Kikkawa F., Shibata K., Tomoda K., Obata N.H., Wakahara F., Tokuhashi Y., Ishikawa H., Kawai M., Tomoda Y. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Gynecol Oncol. 62:1996;67-72.